Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiovascular effects of indoramin in man--a dose ranging study.

Literature DB >> 6849741

Cardiovascular effects of indoramin in man--a dose ranging study.

D P Nicholls, D W Harron, R G Shanks.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Indoles
Indoramin

Year: 1983 PMID： 6849741 PMCID： PMC1427821 DOI： 10.1111/j.1365-2125.1983.tb01459.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

39 in total

1. THE CIRCULATORY EFFECTS OF INTRAVENOUS PHENTOLAMINE IN MAN.

Authors: S H TAYLOR; G R SUTHERLAND; G J MACKENZIE; H P STAUNTON; K W DONALD
Journal: Circulation Date: 1965-05 Impact factor: 29.690

2. Adrenergic mechanisms in the initiation of cardiac arrhythmias.

Authors: H L Garvey
Journal: Arch Int Pharmacodyn Ther Date: 1969-12

3. Pharmacologic studies of indoramin in man.

Authors: R B Royds; D J Coltart; J D Lockhart
Journal: Clin Pharmacol Ther Date: 1972 May-Jun Impact factor: 6.875

4. Myocardial alpha adrenergic receptors and their role in the production of a positive inotropic effect by sympathomimetic agents.

Authors: W C Govier
Journal: J Pharmacol Exp Ther Date: 1968-01 Impact factor: 4.030

5. Interactions between sympathomimetic amines and blocking agents on the rat ventricle strip.

Authors: D G Wenzel; J L Su
Journal: Arch Int Pharmacodyn Ther Date: 1966-04

6. A random-zero sphygmomanometer.

Authors: B M Wright; C F Dore
Journal: Lancet Date: 1970-02-14 Impact factor: 79.321

7. Myocardial effects of indoramin hydrochloride, a new hypotensive agent.

Authors: D J Coltart; S J Meldrum; R B Royds
Journal: Br J Pharmacol Date: 1971-08 Impact factor: 8.739

8. Evidence for adrenergic alpha receptor depressant activity in the heart.

Authors: T N James; E S Bear; K F Lang; E W Green
Journal: Am J Physiol Date: 1968-12

9. The reversal of experimental cardiac arrhythmias by indoramin (Wy 21901).

Authors: B J Alps; M Hill; K Fidler; E S Johnson; A B Wilson
Journal: J Pharm Pharmacol Date: 1971-09 Impact factor: 3.765

10. Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21901).

Authors: B J Alps; M Hill; E S Johnson; A B Wilson
Journal: Br J Pharmacol Date: 1972-01 Impact factor: 8.739

6 in total

1. Haemodynamic and pharmacokinetic evaluation of alfuzosin in man. A dose ranging study and comparison with prazosin.

Authors: M G Scott; A H Deering; M T McMahon; D W Harron; R G Shanks
Journal: Eur J Clin Pharmacol Date: 1989 Impact factor: 2.953

2. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors: D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal: Br J Clin Pharmacol Date: 1984-08 Impact factor: 4.335

Review 3. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors: B Holmes; E M Sorkin
Journal: Drugs Date: 1986-06 Impact factor: 9.546